Skip to content
The Nexus
DossierENTITY

gene-editing

Coverage of gene-editing in the Nexus archive.

Earliest in view: May 26 · 13:50 UTCMost recent: Jun 9 · 04:00 UTC
Co-mentioned in this coverage
Recent coverage
  • SCIENCEJun 9 · 04:00 UTCEURACTIV
    EU gene-editing push meets thorny wine market rules

    The EU's efforts to advance gene-editing may face challenges due to complex wine market regulations, potentially leaving gene-edited Pinot Noir and Riesling in an uncertain legal position.

  • SCIENCEJun 5 · 20:11 UTCNEW SCIENTIST
    Are we getting to the point where it's safe to gene-edit babies?

    A US-based team has achieved promising results using an improved CRISPR method to gene-edit human embryos. However, a significant issue remains unresolved, raising ongoing concerns about safety and ethical implications.

  • SCIENCEJun 4 · 15:07 UTCEURACTIV
    UK gene-editing rules hit by court ruling

    A court ruling has challenged UK gene-editing rules, raising new questions about the labelling of gene-edited food. The decision highlights regulatory uncertainties in the field of genetic modification.

  • HEALTHMay 26 · 13:50 UTCSTAT NEWS
    STAT+: Five biotech news updates to stay on top of today

    Eli Lilly’s gene-editing data shows promise for treating high cholesterol, an AI drug discovery CEO addressed industry hype, and the new interim FDA chief has received positive initial reactions. The article highlights key biotech developments impacting science and regulatory landscapes.